Fig. 5. B7-H3 nanobody-based CAR-T cells exhibit superior persistent antitumor activity against human pancreatic cancer in mice.
a Experimental schema of the Panc-1 metastasis xenograft mouse model (created with BioRender.com). n = 7/8 mice/group. b, c Representative tumor bioluminescence images of mice b and tumor growth curve c measured by bioluminescence. n = 7/8 mice/group. ***P < 0.001, two-tailed unpaired Student’s t test. d Experimental schema of the Panc-1 metastasis xenograft mouse model under tumor-rechallenge (created with BioRender.com). n = 5/7 mice/group. Three mice were used as the control. e, f Representative tumor bioluminescence images of mice e and tumor growth curve f. n = 5/7 mice/group. ***P < 0.001, two-tailed unpaired Student’s t test. g Kaplan-Meier survival curve post-CAR-T cells infusion. ***P < 0.001, Log-rank test. h Tumor metastasis images in mice infused with CD19 or B7-H3 CAR-T cells. Mouse tissues and tumors (GFP) were visualized by the white and UV/blue light, respectively. i Dose-dependent effects of B7-H3 CAR-T cells in the Panc-1 metastasis mouse model (created with BioRender.com). n = 3/5 mice/group. j, k Tumor bioluminescence growth curve with 5 million (j) or 2.5 million (k) B7-H3 CAR-T cells. **P = 0.007, ***P < 0.001, two-tailed unpaired Student’s t test. l Absolute CAR-T count from 100 μl blood was identified in mouse peripheral blood after week 2/3/4 of infusion. n = 3 individual samples/group. Values represent mean ± SEM. *P = 0.16, two-tailed unpaired Student’s t test. m PD-1 expression in circulated CD3+CAR-T cells at week 2/3/4 of infusion. n = 3 individual samples/group. Values represent mean ± SEM. ***P = 0.0006, two-tailed unpaired Student’s t test. n Distribution of memory subsets in CD4+/CD8+ CAR+-T cell subpopulations at week 6 of infusion. n = 3 individual samples/group. Values represent mean ± SEM. o Experimental schema of the Panc-1 orthotopic mouse model (created with BioRender.com). n = 4 mice/group. p Tumor bioluminescence images of orthotopic Panc-1 mice (created with BioRender.com) in the CAR-T treatment groups. CAR-T cells from donor #076’s PBMC. Source data is provided as a Source Data file.